Retagliptin Phosphate (SP 2086) |
Catalog No.GC31472 |
Retagliptin Phosphate (SP 2086) (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1256756-88-3
Sample solution is provided at 25 µL, 10mM.
Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor for treating type-2 diabetes.
[1]. Hu C, et al. Pharmacokinetics of Phosphate Retagliptin Tabletin in Patients with Renal Dysfunction. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Jan;49(1):74-80.
Average Rating: 5
(Based on Reviews and 33 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *